课题基金 / 基金详情

Structure-Function Analysis of Triglyceride Regulators ApoC-III and ApoA-V Using Natural Variants

Structure-Function Analysis of Triglyceride Regulators ApoC-III and ApoA-V Using Natural Variants
使用天然变体对甘油三酯调节剂 ApoC-III 和 ApoA-V 进行结构-功能分析
批准号:
9306180
负责人:
Daniel James Rader
金额:
$39.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2020-06-30

项目摘要

项目成果

Daniel James Rader的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Coronary artery disease (CAD) remains among the highest disease burdens in the modern world. Despite effective treatments focused on specific risk factors such as LDL cholesterol (LDL-C), prevalence and mortality from this disease remains very high. This necessitates investigating additional risk factors and identifying novel targets for treatment. Apolipoproteins C-III and A-V are reciprocal regulators of TG in plasma and were recently implicated through human genetics as being significantly related to risk of developing CAD. Genetic studies suggested that inactivating ApoC-III or enhancing ApoA-V, may protect against CAD. However, we currently have very little understanding of the structure and mechanisms of these two proteins and how the disease-associated mutations exert their effects to regulate TG levels and CAD risk. In this proposal, we seek to elucidate the helical and structural dynamics of the wild-type (WT) forms of these two apolipoproteins in the lipid-free and lipid-bound states through hydrogen-deuterium exchange and mass spectrometry to amino acid- level resolution. We will also study the effects the identified coding mutations on protein folding, dynamics, and lipid binding. We posit that the identified mutations influence lipid binding and cause altered TG metabolism through impacting lipoprotein association, LPL activity, TG-rich lipoprotein clearance and hepatic TG metabolism. We will test hypotheses for how each variant is acting through biochemical approaches and complementary in vivo studies comparing expression of WT and mutant ApoC-III/A-V in humanized mouse models. Finally, we will assess the impact of the CAD-associated ApoC-III/A-V mutations on atherogenesis in vivo. The proposed experiments will decipher the specific mechanisms of action of ApoC-III and ApoA-V in regulating TG metabolism and risk of CAD, and determine the structural features most crucial to these functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Undiagnosed diseases network clinical site
  • 批准号:
    10600336
  • 项目类别:
  • 资助金额:
    $64.44万
  • 财政年份:
    2022
  • 负责人:
    Daniel James Rader
  • 依托单位:
Mechanisms by which ABCA7 activity influences Alzheimer's Disease
  • 批准号:
    10525795
  • 项目类别:
  • 资助金额:
    $212.11万
  • 财政年份:
    2022
  • 负责人:
    Daniel James Rader
  • 依托单位:
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies
  • 批准号:
    10186801
  • 项目类别:
  • 资助金额:
    $70.02万
  • 财政年份:
    2019
  • 负责人:
    Daniel James Rader
  • 依托单位:
Deep phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 human knockouts and population based studies
海外基金